Florida Senate - 2009                                    SB 1356
       
       
       
       By Senator Bennett
       
       
       
       
       21-01257-09                                           20091356__
    1                        A bill to be entitled                      
    2         An act relating to monitoring the dispensing of
    3         controlled substances; creating s. 893.055, F.S.;
    4         providing definitions; requiring the Department of
    5         Health to establish a comprehensive electronic system
    6         to monitor the dispensing of certain controlled
    7         substances; requiring those who dispense certain
    8         controlled substances to submit specified information
    9         to the department; providing exceptions to reporting
   10         requirements; requiring that information be submitted
   11         in an approved electronic format; providing time
   12         periods for information submission; providing criminal
   13         penalties for violations; requiring rulemaking;
   14         providing requirements for system funding; providing
   15         an effective date.
   16         
   17  Be It Enacted by the Legislature of the State of Florida:
   18         
   19         Section 1. Section 893.055, Florida Statutes, is created to
   20  read:
   21         893.055 Electronic monitoring system for the dispensing of
   22  certain controlled substances.—
   23         (1) As used in this section, the term:
   24         (a) “Health care practitioner” or “practitioner” means any
   25  practitioner subject to licensure or regulation by the
   26  department under chapter 458, chapter 459, chapter 461, or
   27  chapter 466.
   28         (b)“Pharmacy” means any pharmacy subject to licensure or
   29  regulation by the department under chapter 465, or that would be
   30  subject to such licensure if it were located in this state, that
   31  dispenses a controlled substance listed in Schedule II, Schedule
   32  III, or Schedule IV to an individual or address in this state.
   33         (2) No later than June 30, 2010, the department shall
   34  design and establish a comprehensive electronic system,
   35  consistent with standards of the American Society for Automation
   36  in Pharmacy, to monitor the prescribing and dispensing of
   37  controlled substances listed in Schedule II, Schedule III, and
   38  Schedule IV by health care practitioners and the dispensing of
   39  such controlled substances to an individual or address in this
   40  state by a pharmacy required to be permitted or registered by
   41  the Board of Pharmacy or through a dispensing transaction with a
   42  pharmacy not located in this state that is otherwise subject to
   43  the jurisdiction of this state as to that dispensing
   44  transaction. The department may contract with another state
   45  agency or with a private vendor to establish and maintain the
   46  system.
   47         (3) Except as provided in subsection (4), each time a
   48  controlled substance listed in Schedule II, Schedule III, or
   49  Schedule IV is dispensed to an individual or address in this
   50  state, the pharmacy or dispensing practitioner shall report to
   51  the department information determined by rule of the department
   52  that shall include, but not be limited to, the following:
   53         (a)1.The full name, address, date of birth, and social
   54  security number of the patient for whom, or the owner of the
   55  animal for which, the controlled substance is dispensed.
   56         2.If the prescription is for an animal, the species of the
   57  animal for which the controlled substance is prescribed.
   58         (b) The name, strength, quantity, and National Drug Code
   59  (NDC) number of the controlled substance dispensed.
   60         (c) The full name, address, and federal controlled
   61  substance registry number of the prescribing practitioner.
   62         (d) The date the prescription was issued by the prescribing
   63  practitioner.
   64         (e) The full name, address, and federal controlled
   65  substance registry number of the pharmacy or dispensing
   66  practitioner.
   67         (f) The date the prescription was filled by the pharmacy or
   68  dispensing practitioner.
   69         (g) The number of the prescription as recorded in the
   70  prescription files of the pharmacy in which it is filled.
   71         (4) This section does not apply to controlled substances:
   72         (a) Administered by a health care practitioner directly to
   73  a patient.
   74         (b) Dispensed by a health care practitioner authorized to
   75  prescribe controlled substances directly to a patient and
   76  limited to an amount adequate to treat the patient for a period
   77  of not more than 72 hours.
   78         (c) Dispensed by a health care practitioner or a pharmacist
   79  to an inpatient of a facility that holds an institutional
   80  pharmacy permit.
   81         (d) Ordered from an institutional pharmacy permitted under
   82  s. 465.019 in accordance with the institutional policy for such
   83  controlled substances.
   84         (e) Administered by a health care practitioner to a patient
   85  or resident receiving care from a hospital, nursing home,
   86  assisted living facility, home health agency, hospice, or
   87  intermediate care facility for the developmentally disabled that
   88  is licensed in this state.
   89         (5) A practitioner or pharmacist whose dispensing of a
   90  controlled substance is required to be reported under this
   91  section must submit the information required by this section in
   92  an electronic or other format approved by rule of the
   93  department. The cost to the practitioner or pharmacist in
   94  submitting the information required by this section may not be
   95  material or extraordinary.
   96         (6) A practitioner or pharmacist who dispenses a controlled
   97  substance under this section must, unless an extension is
   98  approved by the department for cause, submit the information
   99  required by subsection (3) within 14 days after dispensing a
  100  controlled substance during the first year of the system's
  101  operation and within 7 days after dispensing a controlled
  102  substance in each year thereafter.
  103         (7) Any person who knowingly fails to report the dispensing
  104  of a controlled substance as required by this section commits a
  105  misdemeanor of the first degree, punishable as provided in s.
  106  775.082 or s. 775.083.
  107         (8) The department and the regulatory boards for the health
  108  care practitioners subject to this section shall adopt rules
  109  pursuant to ss. 120.536(1) and 120.54 to administer this
  110  section.
  111         (9) All costs incurred by the department in administering
  112  the system shall be funded through federal, private, or grant
  113  funding. State funds may be used to the extent that they are
  114  available.
  115         Section 2. This act shall take effect July 1, 2009.